• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.

作者信息

Golwala Harsh, Bajaj Navkaranbir Singh, Arora Garima, Arora Pankaj

机构信息

From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.).

出版信息

Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.

DOI:10.1161/CIRCULATIONAHA.116.026056
PMID:27993908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5416382/
Abstract
摘要

相似文献

1
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.用于非缺血性心肌病的植入式心脏复律除颤器：一项更新的荟萃分析。
Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.
2
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.用于非缺血性心肌病患者一级预防的植入式心脏复律除颤器：一项系统评价和荟萃分析。
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12253.
3
Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.植入式心脏复律除颤器用于非缺血性心肌病患者心脏性猝死的一级预防
Angiology. 2018 Apr;69(4):297-302. doi: 10.1177/0003319717710851. Epub 2017 May 30.
4
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.非缺血性心肌病患者的一级预防植入型心律转复除颤器：一项荟萃分析。
JAMA Cardiol. 2017 Jun 1;2(6):685-688. doi: 10.1001/jamacardio.2017.0630.
5
Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.植入式心律转复除颤器在非缺血性心肌病一级预防中的死亡率影响：一项随机对照试验的荟萃分析
J Cardiovasc Electrophysiol. 2017 May;28(5):538-543. doi: 10.1111/jce.13192. Epub 2017 Mar 30.
6
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.老年患者中一级预防植入式心脏复律除颤器的生存获益：年龄有影响吗？来自5项临床试验的汇总数据分析
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):179-86. doi: 10.1161/CIRCOUTCOMES.114.001306. Epub 2015 Feb 10.
7
Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.非缺血性心肌病、心源性猝死和植入式除颤器：综述和荟萃分析。
Heart. 2018 Jan;104(2):144-150. doi: 10.1136/heartjnl-2016-310850. Epub 2017 Oct 6.
8
Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".巴拉卡特等人就“用于非缺血性心肌病的植入式心脏复律除颤器：一项更新的荟萃分析”一文所写的信。
Circulation. 2017 Jun 20;135(25):e1196-e1197. doi: 10.1161/CIRCULATIONAHA.116.027106.
9
Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".内里等人就“用于非缺血性心肌病的植入式心脏复律除颤器：一项更新的荟萃分析”一文所写的信。
Circulation. 2017 Jun 20;135(25):e1198-e1199. doi: 10.1161/CIRCULATIONAHA.117.027389.
10
Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".戈尔瓦拉等人对关于“非缺血性心肌病的植入式心脏复律除颤器：一项更新的荟萃分析”一文的信函的回应。
Circulation. 2017 Jun 20;135(25):e1200-e1202. doi: 10.1161/CIRCULATIONAHA.117.028200.

引用本文的文献

1
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias.《日本循环学会/日本心律学会2024年心律失常管理指南重点更新》
J Arrhythm. 2025 Jun 16;41(3):e70033. doi: 10.1002/joa3.70033. eCollection 2025 Jun.
2
Radiomic Cardiac MRI Signatures for Predicting Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy.用于预测非缺血性扩张型心肌病患者室性心律失常的放射组学心脏磁共振成像特征
JACC Adv. 2025 Apr;4(4):101684. doi: 10.1016/j.jacadv.2025.101684. Epub 2025 Mar 23.
3
Current and Future of Heart Failure Care in Asia.亚洲心力衰竭护理的现状与未来。
Int J Heart Fail. 2024 Oct 25;6(4):141-148. doi: 10.36628/ijhf.2024.0033. eCollection 2024 Oct.
4
Enhancing patient acceptance of ICD implantation through structured shared decision making: conversation is key.通过结构化的共同决策提高患者对植入式心律转复除颤器（ICD）植入的接受度：沟通是关键。
J Interv Card Electrophysiol. 2024 Dec;67(9):2077-2087. doi: 10.1007/s10840-024-01850-7. Epub 2024 Jul 13.
5
Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias.多模态可解释人工智能识别出患有非缺血性心肌病且有致命性室性心律失常风险的患者。
Sci Rep. 2024 Jun 27;14(1):14889. doi: 10.1038/s41598-024-65357-x.
6
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions.植入式心脏复律除颤器心动过速治疗：过去、现在与未来方向
J Cardiovasc Dev Dis. 2024 Mar 20;11(3):92. doi: 10.3390/jcdd11030092.
7
An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy.非缺血性心肌病患者接受或未接受除颤的心脏再同步治疗的最新荟萃分析。
Front Cardiovasc Med. 2023 Jul 12;10:1078570. doi: 10.3389/fcvm.2023.1078570. eCollection 2023.
8
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy-a nationwide cohort study.年龄分层比较非缺血性心肌病心脏再同步治疗伴或不伴预防性除颤器的预后：一项全国性队列研究。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad187.
9
Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia.亚洲地区植入式心脏复律除颤器用于心脏性猝死一级预防的应用情况
JACC Asia. 2023 Apr 25;3(3):335-345. doi: 10.1016/j.jacasi.2023.02.004. eCollection 2023 Jun.
10
Sex differences in one-year recurrence and all-cause mortality following catheter ablation of ventricular tachycardia in structural heart disease.结构性心脏病患者室性心动过速导管消融术后一年复发率及全因死亡率的性别差异
Front Cardiovasc Med. 2022 Dec 6;9:1061471. doi: 10.3389/fcvm.2022.1061471. eCollection 2022.

本文引用的文献

1
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
2
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.2012年美国心脏病学会基金会/美国心脏协会/心律学会重点更新内容纳入《2008年美国心脏病学会基金会/美国心脏协会/心律学会心脏节律异常器械治疗指南》：美国心脏病学会基金会/美国心脏协会实践指南工作组及心律学会报告
Circulation. 2013 Jan 22;127(3):e283-352. doi: 10.1161/CIR.0b013e318276ce9b. Epub 2012 Dec 19.
3
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.植入式除颤器预防非缺血性心肌病患者死亡：随机对照试验的荟萃分析
JAMA. 2004 Dec 15;292(23):2874-9. doi: 10.1001/jama.292.23.2874.
4
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.左心室收缩功能障碍患者的预防性植入式心脏复律除颤器治疗：10项一级预防试验的汇总分析
J Am Coll Cardiol. 2004 Dec 7;44(11):2166-72. doi: 10.1016/j.jacc.2004.08.054.
5
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.初始病因不明的心肌病患者的潜在病因及长期生存情况
N Engl J Med. 2000 Apr 13;342(15):1077-84. doi: 10.1056/NEJM200004133421502.